Immediate Funding for Tunisia's Central Pharmacy to Restore Normal Supply Chain
The Central Pharmacy of Tunisia will immediately receive the necessary funding to regain a normal supply rhythm. Yesterday, on March 30, the head of government held a restricted ministerial council meeting. The topic: reform of the healthcare system and social coverage. The most immediate decision concerns the Tunisian Central Pharmacy, with its credits being released without delay.
Current Situation
The assessment is severe, with persistent drug shortages in hospitals and pharmacies. Some regions are more affected than others, making this situation no longer acceptable. The Minister of Health presented a detailed report, outlining the actions taken since the previous council meetings and what still needs to be corrected.
Roadmap for Improvement
The adopted roadmap revolves around several immediate axes:
- Financial Guarantee: Ensure the Central Pharmacy's credits are secured.
- Strategic Stockpiling: Establish security stocks, prioritizing vital and special medications.
- Digitalization: Complete digitization of the pharmaceutical chain to track stocks, distribution circuits, and local market supply in real-time, preventing unnoticed disruptions.
- Enhanced Control and Transparency: Strengthen control at every link in the pharmaceutical chain, making transparency in management a formal requirement rather than a recommendation.
The head of government recalled the recommendations from the ministerial council meeting on September 3, 2025, which had been partially unaddressed.
